Mark S. Dykewicz, M.D.
Director, Division of Allergy and Immunology; Raymond and Alberta Slavin Endowed Professor
in Allergy and Immunology; Program director, Allergy and Immunology Fellowship Program; Professor
Department of Internal Medicine
Education
Fellowship
Northwestern University Medical School
Residency
Northwestern University Medical School
Medical School
Saint Louis University School of Medicine
Bachelor of Science
University of Michigan
Practice Areas
Mark Dykewicz, M.D., is a physician, educator, researcher, consultant and author, known nationally
for expertise in the field of allergy and immunology.
As a SLUCare specialist, Dykewicz treats asthma, rhinitis and sinusitis, as well as
allergies to food, drugs and stinging insects, including reactions such as anaphylaxis
and hives.
Research Interests
- Provided safety oversight for the development of 15 vaccines under 20 multi-center protocols of the National Institute of Allergy and Infectious Diseases
Publications and Media Placements
Dykewicz has authored/co-authored national and international clinical care guidelines on a range of diseases, most recently as lead editor of “Rhinitis 2020: A Practice Parameter Update.” He has more than 180 academic publications on topics ranging from drug allergy, anaphylaxis, rhinosinusitis, occupational asthma and angioedema, including the first report that patients with histories of idiopathic angioedema are at increased risk for more frequent and severe episodes of angioedema when taking ACE-inhibitors.
Honors and Awards
- Special Recognition Award - American Academy of Allergy, Asthma and Immunology
- Distinguished Service Award - American College of Allergy, Asthma and Immunology
Professional Organizations and Associations
- Member, FDA Vaccines and Related Biological Products Advisory Committee
- Past chair, FDA's Pulmonary Allergy Drug Advisory Committee
- Past advisor
- FDA Center for Drug Evaluation and Research
- Center for Biologics Evaluation and Research
- Center for Devices and Radiological Health